Malignant effusions: from diagnosis to biology

Area of Science:

• Oncology
• Pathology
• Cell Biology

Background:

• Serous effusions are common in metastatic disease, often from breast, ovarian, lung cancers, and malignant mesothelioma.
• Advances in antibody panels improve effusion diagnosis, but understanding cancer cell biology in effusions remains limited, especially for non-ovarian origins.

Purpose of the Study:

• To review current knowledge on the biology of cancer cells in effusions.
• To propose a model for studying tumor metastasis and disease progression using comparative analysis.
• To highlight potential clinical applications in diagnosing and classifying effusions.

Main Methods:

• Literature review of current research on cancer cells in effusions.
• Comparative analysis of malignant cells from effusions, primary tumors, and solid metastases.
• Discussion of phenotypic and genotypic characteristics of cancer cells from different origins.

Main Results:

• Malignant effusions signify disease progression and are linked to poorer prognoses.
• Ovarian cancer shows more variable survival rates compared to other tumors in effusions.
• Cancer cells exhibit distinct biological, phenotypic, and genotypic traits based on origin.

Conclusions:

• Further research into the biology of cancer cells in effusions is needed.
• A comparative study model can advance understanding of tumor metastasis and progression.
• Knowledge gained can improve clinical diagnosis, classification, and prediction of behavior for malignant effusions.